Investigating HLH

Adam Narloch speaks with Dr Ashish Kumar and Dr Scott Canna to discuss the challenges involved with diagnosing and managing HLH. Dr Kumar is a pediatric hematologist- oncologist, and a director of the Histiocytosis Center at Cincinnati Children's Hospital. Dr Scott Canna is a pediatric rheumatologist and an Assistant Professor of Pediatrics at Children’s Hospital of Philadelphia. Hear from these 2 experts about why a prompt diagnosis is critical for patients with HLH—and why it can be so difficult to achieve.Follow UsYouTube @Sobi-PharmaLinkedin @SobiPresented by Sobi Inc.https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 

Adam Narloch speaks with Dr Michelle Hermiston to discuss the history of HLH and advances in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH!Follow UsYouTube @Sobi-PharmaLinkedin @SobiPresented by Sobi Inc.https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23 

In this episode of Investigating HLH, Adam Narloch, a Thought Leader Liaison at Sobi, speaks with Dr Michelle Hermiston to discuss the history of HLH and advances that have been made in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH!Follow UsYouTube @Sobi-PharmaLinkedIn @SobiPresented by Sobi Inc.https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23